European regulators have given CE mark approval to AnteoTech for its EuGeni Reader and EuGeni COVID-19 Antigen Rapid Test that has a 99.6% specificity and 97.3% sensitivity.
EU OKs rapid test platform, COVID-19 test from AnteoTech
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.